Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials

Detalles Bibliográficos
Autores principales: Wolf, Myles, Auerbach, Michael, Kalra, Philip A., Glaspy, John, Thomsen, Lars L., Bhandari, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756775/
https://www.ncbi.nlm.nih.gov/pubmed/33027541
http://dx.doi.org/10.1002/ajh.26015
_version_ 1783626615070130176
author Wolf, Myles
Auerbach, Michael
Kalra, Philip A.
Glaspy, John
Thomsen, Lars L.
Bhandari, Sunil
author_facet Wolf, Myles
Auerbach, Michael
Kalra, Philip A.
Glaspy, John
Thomsen, Lars L.
Bhandari, Sunil
author_sort Wolf, Myles
collection PubMed
description
format Online
Article
Text
id pubmed-7756775
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-77567752020-12-28 Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials Wolf, Myles Auerbach, Michael Kalra, Philip A. Glaspy, John Thomsen, Lars L. Bhandari, Sunil Am J Hematol Correspondence John Wiley & Sons, Inc. 2020-10-27 2021-01 /pmc/articles/PMC7756775/ /pubmed/33027541 http://dx.doi.org/10.1002/ajh.26015 Text en © 2020 The Authors. American Journal of Hematology published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Wolf, Myles
Auerbach, Michael
Kalra, Philip A.
Glaspy, John
Thomsen, Lars L.
Bhandari, Sunil
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title_full Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title_fullStr Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title_full_unstemmed Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title_short Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
title_sort safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: the ferwon‐ida/nephro trials
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756775/
https://www.ncbi.nlm.nih.gov/pubmed/33027541
http://dx.doi.org/10.1002/ajh.26015
work_keys_str_mv AT wolfmyles safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials
AT auerbachmichael safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials
AT kalraphilipa safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials
AT glaspyjohn safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials
AT thomsenlarsl safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials
AT bhandarisunil safetyofferricderisomaltoseandironsucroseinpatientswithirondeficiencyanemiatheferwonidanephrotrials

Ejemplares similares